In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Viatris’ current price of $17.73 lies below the fair value estimate of $20.88, indicating potential undervaluation with a high-confidence upside near 18%. Financial health is poor, with zero profitability and efficiency but moderate liquidity and leverage, raising concerns about operational stability. Monte Carlo analysis shows high volatility (45% coefficient of variation) but limited downside risk (22%), reflecting significant uncertainty balanced by upside potential.